Development and Characterization of Combinational Formulations of Artemether and Lumefantrine in Mcroneedles, Nanosponges and Dry Syrup in Nanoparticulate form

Схожие документы

• Development and Characterization of Combinational Formulations of Artemether and Lumefantrine in Microneedles, Nanosponges and Dry Syrup in Nanoparticulate From
  по: Sandip Pawar
  Опубликовано: (2020)
• Formulation and Characterization of Tetanus Toxoid Nanoparticulate Microneedles
  по: Mansi Waghchaure
• Formulation Development of Artemether and Lumefantrine for Improvement of Solubility and Dissolution Rate for Oral Drug Delivery (Tablet)
  по: Rohit Patel
  Опубликовано: (2017)
• Formulation and Characterization of Nanoparticulate-based-Theranostic System for Rheumatoid Arthritis
  по: Gandhi Sahil
• Optimization and Evaluation of Dry Syrup Containing Antibiotic Combination (Drug X and Drug Y) for Veterinary Use
  по: Minaxi Salunke
  Опубликовано: (2017)